Los Angeles Capital Management LLC Denali Therapeutics Inc. Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

A detailed history of Los Angeles Capital Management LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 27,940 shares of DNLI stock, worth $582,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,940

Previous 52,863 47.15%

Holding current value

$582,269

Previous $1.23 Million 33.74%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$20.96 - $31.05 $522,386 - $773,859	-24,923 Reduced 47.15%	27,940 $813,000
Q2 2024 Aug 05, 2024	SELL	$14.96 - $23.22 $41,125 - $63,831	-2,749 Reduced 4.94%	52,863 $1.23 Million
Q1 2024 Apr 05, 2024	BUY	$15.83 - $23.35 $143,324 - $211,410	9,054 Added 19.45%	55,612 $1.14 Million
Q4 2023 Feb 06, 2024	BUY	$16.2 - $23.18 $9,007 - $12,888	556 Added 1.21%	46,558 $999,000
Q3 2023 Nov 06, 2023	BUY	$20.63 - $30.17 $21,578 - $31,557	1,046 Added 2.33%	46,002 $949,000
Q2 2023 Aug 03, 2023	BUY	$23.37 - $32.96 $618,113 - $871,759	26,449 Added 142.91%	44,956 $1.33 Million
Q1 2023 May 04, 2023	SELL	$21.91 - $32.67 $52,474 - $78,244	-2,395 Reduced 11.46%	18,507 $426,000
Q4 2022 Feb 06, 2023	SELL	$26.28 - $33.92 $573,928 - $740,778	-21,839 Reduced 51.1%	20,902 $581,000
Q3 2022 Nov 02, 2022	SELL	$25.97 - $38.53 $30,592 - $45,388	-1,178 Reduced 2.68%	42,741 $1.31 Million
Q2 2022 Aug 05, 2022	BUY	$20.88 - $35.19 $34,806 - $58,661	1,667 Added 3.95%	43,919 $1.29 Million
Q1 2022 May 06, 2022	BUY	$29.0 - $47.27 $33,640 - $54,833	1,160 Added 2.82%	42,252 $1.36 Million
Q4 2021 Feb 03, 2022	SELL	$42.59 - $55.02 $18,313 - $23,658	-430 Reduced 1.04%	41,092 $1.83 Million
Q3 2021 Nov 08, 2021	BUY	$48.48 - $78.23 $392,203 - $632,880	8,090 Added 24.2%	41,522 $2.1 Million
Q2 2021 Aug 05, 2021	BUY	$50.3 - $78.44 $827,787 - $1.29 Million	16,457 Added 96.95%	33,432 $2.62 Million
Q1 2021 May 05, 2021	SELL	$53.8 - $81.53 $220,633 - $334,354	-4,101 Reduced 19.46%	16,975 $969,000
Q4 2020 Feb 04, 2021	BUY	$36.89 - $93.56 $443,602 - $1.13 Million	12,025 Added 132.86%	21,076 $1.77 Million
Q3 2020 Nov 02, 2020	SELL	$23.13 - $38.84 $157,954 - $265,238	-6,829 Reduced 43.0%	9,051 $324,000
Q2 2020 Aug 05, 2020	SELL	$16.01 - $28.82 $66,761 - $120,179	-4,170 Reduced 20.8%	15,880 $383,000
Q1 2020 May 04, 2020	BUY	$14.2 - $27.98 $284,710 - $560,999	20,050 New	20,050 $351,000

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.8B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Denali Therapeutics Inc. Transaction History